Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation
- PMID: 21779185
- PMCID: PMC3129342
- DOI: 10.3343/kjlm.2011.31.3.143
Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation
Abstract
Background: Fibrin-related markers (FRM) such as fibrin monomer (FM) and D-dimer (DD) are considered useful biological markers for the diagnosis of disseminated intravascular coagulation (DIC). However, no studies on the diagnostic performance of different FRMs have been published in Korea. The aim of this study was to evaluate the diagnostic performance of FM for DIC in comparison with DD.
Methods: The reference limit of FM was determined based on plasma sample data obtained from 210 control individuals. To evaluate diagnostic performance, FM data from the plasma samples of 139 patients with DIC-associated diseases were obtained for DIC scoring. FM was measured by immunoturbidimetry using STA-LIATEST FM (Diagnostica Stago, France). Patients were classified according to the DIC score as non-DIC, non-overt DIC, or overt DIC. ROC curve analyses were performed.
Results: The reference limit in the control individuals was determined to be 7.80 µg/mL. Patients with DIC-associated diseases were categorized as non-DIC (N=43), non-overt DIC (N=80), and overt DIC (N=16). ROC curve analyses showed that the diagnostic performance of FM was comparable to DD in both non-overt DIC and overt DIC (P=0.596 and 0.553, respectively). In addition, FM had higher sensitivity, specificity, positive predictive value, and negative predictive value than DD for differentiating overt DIC from non-DIC.
Conclusions: This study demonstrated that the diagnostic performance of FM for DIC was comparable to DD. FM might be more sensitive and more specific than DD in the diagnosis of overt DIC, but not non-overt DIC.
Keywords: Area under the curve (AUC); D-dimer (DD); Disseminated intravascular coagulation (DIC); Fibrin monomer (FM); Fibrin-related marker (FRM); ROC.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Evaluation of the Diagnostic Performance of Fibrin Monomer in Comparison to d-Dimer in Patients With Overt and Nonovert Disseminated Intravascular Coagulation.Clin Appl Thromb Hemost. 2017 Jul;23(5):460-465. doi: 10.1177/1076029615615959. Epub 2015 Nov 15. Clin Appl Thromb Hemost. 2017. PMID: 26574574 Clinical Trial.
-
Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation.Blood Coagul Fibrinolysis. 2021 Jun 1;32(4):248-252. doi: 10.1097/MBC.0000000000001025. Blood Coagul Fibrinolysis. 2021. PMID: 33955858
-
Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.Thromb Haemost. 2004 Apr;91(4):812-8. doi: 10.1160/TH03-09-0577. Thromb Haemost. 2004. PMID: 15045145
-
[A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].Rinsho Byori. 2004 Apr;52(4):355-61. Rinsho Byori. 2004. PMID: 15164605 Review. Japanese.
-
Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.Semin Thromb Hemost. 2001 Dec;27(6):657-66. doi: 10.1055/s-2001-18870. Semin Thromb Hemost. 2001. PMID: 11740689 Review.
Cited by
-
Reference Value Fibrin Monomer in Healthy Children: A Cross-Sectional Study.Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241247560. doi: 10.1177/10760296241247560. Clin Appl Thromb Hemost. 2024. PMID: 38656143 Free PMC article.
-
Biomarkers of deep venous thrombosis.J Thromb Thrombolysis. 2012 Oct;34(3):335-46. doi: 10.1007/s11239-012-0721-y. J Thromb Thrombolysis. 2012. PMID: 22528325 Review.
-
FM Combined With NIHSS Score Contributes to Early AIS Diagnosis and Differential Diagnosis of Cardiogenic and Non-Cardiogenic AIS.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211000129. doi: 10.1177/10760296211000129. Clin Appl Thromb Hemost. 2021. PMID: 33724895 Free PMC article.
-
Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications.Ann Intensive Care. 2025 Jan 17;15(1):12. doi: 10.1186/s13613-025-01434-2. Ann Intensive Care. 2025. PMID: 39821561 Free PMC article. Review.
References
-
- Levi M, Toh CH, Thachil J, Watson HG British Committee for Standards in Haematology. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145:24–33. - PubMed
-
- Toh CH, Hoots WK. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost. 2007;5:604–606. - PubMed
-
- Taylor FB, Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–1330. - PubMed
-
- Wada H, Sakuragawa N. Are fibrin-related markers useful for the diagnosis of thrombosis? Semin Thromb Hemost. 2008;34:33–38. - PubMed
-
- Wada H, Sase T, Matsumoto T, Kushiya F, Sakakura M, Mori Y, et al. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2003;9:233–240. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources